Algeta ASA (ALGETA.OL)

ALGETA.OL on Oslo Stock Exchange

243.00NOK
10:25am EDT
Price Change (% chg)

kr-1.60 (-0.65%)
Prev Close
kr244.60
Open
kr245.00
Day's High
kr248.00
Day's Low
kr241.30
Volume
36,732
Avg. Vol
192,581
52-wk High
kr251.70
52-wk Low
kr139.50

ALGETA.OL

Chart for ALGETA.OL

About

Algeta ASA is a Norway-based biotechnology company engaged in the development of targeted cancer therapies based on its alpha-pharmaceutical platform. The Company’s principal product is Alpharadin for the treatment of bone metastases resulting from castration-resistant prostate cancer. The Company’s pipeline also includes... (more)

Overall

Beta: 1.39
Market Cap (Mil.): kr10,706.55
Shares Outstanding (Mil.): 43.77
Dividend: --
Yield (%): --

Financials

  ALGETA.OL Industry Sector
P/E (TTM): 68.55 44.65 37.87
EPS (TTM): 3.57 -- --
ROI: 26.93 -2.30 18.70
ROE: 27.59 -2.12 19.53
Search Stocks

Bayer, Algeta win FDA approval for prostate cancer drug

FRANKFURT, May 15 - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales.

15 May 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$460.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks